Rx (Prescription Medicine)
Biopanib 200毫克片剂是一种靶向癌症治疗药物，用于治疗某些晚期癌症。它通过抑制癌细胞生长发挥作用，应按照医生的处方服用。
Biopanib 200毫克片剂是一种靶向治疗药物，用于治疗某些类型的癌症。其活性成分Biopanib通过抑制对癌细胞生长和增殖至关重要的特定酶发挥作用。这种机制有助于减缓或阻止疾病的进展。
Biopanib 200毫克片剂主要适用于其他治疗方案可能已用尽的晚期或转移性癌症患者。咨询合格的医疗专业人员以确定Biopanib是否适合您的具体病情至关重要。
重要注意事项：本药物应在肿瘤科医生的严格监督下使用。患者应告知医生任何既往病史，特别是肝脏或肾脏问题，以及正在服用的任何其他药物。可能会出现潜在的副作用，应立即向医生报告。
剂型：口服片剂。
储存：将Biopanib 200毫克片剂储存在室温下，避免阳光直射和潮湿。请置于儿童接触不到的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Pack Quantity | |
| Country Of Origin | |
| Packaging Type | |
| Strength | |
| Brand Name | |
| Molecule | |
| Strength | 200 Mg |
| Medicine Form | Tablet |
| Pack Quantity | 30 Tablets |
| Packaging Type | Strip |
| Medicine Type | Generic |
| Country Of Origin | India |
| Rx Status | Rx (Prescription Medicine) |
其他品牌的 Pazopanib 200 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
